Detection Technology (DETEC) SEB Nordic Seminar presentation summary
Event summary combining transcript, slides, and related documents.
SEB Nordic Seminar presentation summary
19 Jan, 2026Market position and business overview
Global provider of X-ray detector solutions for medical, security, and industrial imaging, serving over 600 active customers in 40+ countries.
Over 2 billion daily scans powered by its technology, with 8 million+ solutions shipped and 2 million+ CT solutions delivered.
Trusted by 10+ Fortune 500 companies and 500+ world-class brands.
Recognized for innovation, quality, reliability, and strategic collaboration, with a 7 ppm customer return rate and nearly 100% on-time delivery.
Selected by leading EV battery manufacturers for technical competence, agility, and high imaging performance.
Product portfolio and innovation
Offers the world's widest portfolio of off-the-shelf and modular X-ray detector solutions, including CT, line scan, flat panel, and photon-counting detectors.
Focus on smart, data-generating detectors and outstanding usability to drive customer success.
Expanding into high-volume a-Si-TFT segment with a scalable, cost-effective flat panel platform.
Integrated software, AI, and algorithms enhance image quality and enable low-dose, high-quality 3D imaging.
Leading in photon-counting technology for next-generation X-ray imaging with lower dose and higher resolution.
Financial performance and targets
2024 net sales reached €108M with EBITA of €15M; estimated 20% global market share in line scan and CT.
Q1-Q3 2025 net sales at €71.3M, down 6% year-on-year, with EBITA margin at 8.3%.
Medium-term targets: annual sales growth >10%, operating margin (EBITA) 15%, and annual dividend payout of 30-60%.
Aims for €170M net sales by 2030, adding €65M through organic growth and acquisitions.
Asset-light business model and strong financial position support investments in future growth.
Latest events from Detection Technology
- 2025 ended with lower sales and profit, but 2026 guidance signals strong growth ahead.DETEC
Q4 20255 Feb 2026 - Q2 2024 saw 3.5% sales growth and record industrial gains, with double-digit H2 growth expected.DETEC
Q2 20242 Feb 2026 - Profitability and cash flow surged, with double-digit sales growth expected in Q2 2025.DETEC
Q4 20243 Dec 2025 - Sales and profitability declined, but medical and industrial segments showed resilience.DETEC
Q2 202523 Nov 2025 - 2030 plan targets 10% growth and 15% EBITA via innovation, TFT expansion, and global reach.DETEC
CMD 202519 Nov 2025 - Net sales fell 8.8% in Q3 2025, with cost-saving actions and double-digit growth expected in Q1 2026.DETEC
Q3 202530 Oct 2025 - Q3 sales up 10.6%, EBITA margin 15.3%, security and industrial units led growth.DETEC
Q3 202413 Jun 2025 - Sales fell 2% as security demand dropped, but medical and industrial segments grew.DETEC
Q1 20255 Jun 2025